CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

IDH2 R140/R172 mutation

Gene: IDH2 · Type: mutation

Indications: Acute myeloid leukemia

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
EnasidenibAcute myeloid leukemiaINDICATED
FDA Label
Label